First Close of Emerald Global Water Fund II Reaches EUR 60 Million

(NYSE:VLTO),(NYSE:ECL), ZÜRICH, Oct. 30, 2025 (GLOBE NEWSWIRE) — Emerald Technology Ventures, a globally recognized venture capital firm with two decades of water-sector leadership, announced the first close of its Global Water Fund II at EUR60 million, marking a significant milestone in the fund's mission to advance water innovation worldwide. The fund's anchor investors are Veralto […]

onsemi Unveils Vertical GaN Semiconductors: A Breakthrough for AI and Electrification

(NASDAQ:ON), Scottsdale, Ariz, Oct. 30, 2025 (GLOBE NEWSWIRE) — Summary — As global energy demand surges from AI data centers, electric vehicles, and other energy intensive applications, onsemi has introduced vertical gallium nitride (vGaN) power semiconductors, setting a new benchmark for power density, efficiency and ruggedness for these applications. These groundbreaking next-generation GaN-on-GaN power semiconductors

Integra LifeSciences Reports Third Quarter 2025 Financial Results

(NASDAQ:IART), PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025. Third Quarter 2025 Highlights Third quarter revenues of $402.1 million increased 5.6% on a reported basis and 5.0% on an organic basis

LXP Industrial Trust Reports Third Quarter 2025 Results

(NYSE:LXP), WEST PALM BEACH, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — LXP Industrial Trust (“LXP”) (NYSE: LXP), a real estate investment trust focused on Class A warehouse and distribution real estate investments, today announced results for the quarter ended September 30, 2025. Third Quarter 2025 Highlights Recorded Net Income attributable to common shareholders of $34.6

Nucific BIO-X4 Wins “2025 Weight Management Product of the Year” Mindful Award

LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) — Nucific(R), founded by leading nutrition expert Dr. Amy Lee, has been recognized by the 2025 Mindful Awards. The brand's best-selling product, BIO-X4(TM), was named “Weight Management Product of the Year”, highlighting its innovation and effectiveness in supporting healthy weight management. “I'm truly honored that Nucific BIO-X4 has

Perimeter Solutions Reports Third Quarter 2025 Financial Results

(NYSE:PRM), Third quarter Net Loss of $90.7M and Adjusted Net Income of $125.5M Continued value driver execution drove third quarter Adjusted EBITDA of $186.3M Third quarter Loss Per Diluted Share of $0.62 and Adjusted Earnings Per Diluted Share of $0.82 IMS add-on product lines acquired CLAYTON, Mo., Oct. 30, 2025 (GLOBE NEWSWIRE) — Perimeter Solutions,

RefMed Launches TruePrice: A UCR Fee Schedule Solution Powered by Real-Time Contract Data

LAKELAND, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — RefMed, a leading provider of market-based pricing and fee schedule solutions for healthcare stakeholders, today announced the launch of TruePrice, a transformative solution for Usual, Customary, and Reasonable (UCR) fee schedules that sets a new standard for accuracy and accessibility in healthcare pricing data. Unlike traditional UCR

Sapu Nano to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle(TM) Everolimus)

Sapu Nano to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle(TM) Everolimus) GlobeNewswire October 30, 2025 AGOURA HILLS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat cancer patients by leveraging its novel

TOLREMO therapeutics Welcomes Multiple Myeloma Leader Kenneth C. Anderson to its Scientific Advisory Board

Basel, October 30, 2025 – TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Kenneth C. Anderson, MD, a globally recognized leader in multiple myeloma research, to the company's Scientific Advisory Board (SAB). His unparalleled expertise in translational and clinical research in multiple myeloma will guide TOLREMO as it expands the clinical development program for

Bahamas Ministry of Tourism, Investments & Aviation Statement on Hurricane Melissa

Bahamas Ministry of Tourism, Investments & Aviation Statement on Hurricane Melissa GlobeNewswire October 30, 2025 Nassau, The Bahamas, Oct. 30, 2025 (GLOBE NEWSWIRE) — The Bahamas Ministry of Tourism, Investments & Aviation extends its heartfelt thoughts and prayers to our neighbors across the region and to residents of the central and southeast islands currently experiencing

Scroll to Top